| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1S SLC2A8 ABCA12 SLCO2B1 KCNV2 ABCB5 SLC5A7 MFSD2B SLCO3A1 SLCO1B3 SLC35E2B SLCO1B1 SLC18B1 CHRNA1 ABCA8 SLC47A2 CHRNA3 SLCO5A1 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 SLC22A14 SLC22A13 SLC22A3 UCP3 SCN7A SLC6A5 APOL4 KCNN1 SLC47A1 ABCD2 MFSD1 DISP1 | 9.36e-20 | 1180 | 110 | 38 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1S SLC2A8 ABCA12 SLCO2B1 KCNV2 ABCB5 SLC5A7 MFSD2B SLCO3A1 SLCO1B3 SLC35E2B SLCO1B1 SLC18B1 CHRNA1 ABCA8 SLC47A2 CHRNA3 SLCO5A1 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 SLC22A14 SLC22A13 SLC22A3 UCP3 NPC1L1 SCN7A SLC6A5 APOL4 KCNN1 SLC47A1 ABCD2 MFSD1 DISP1 | 2.32e-19 | 1289 | 110 | 39 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC2A8 ABCA12 SLCO2B1 ABCB5 SLC5A7 MFSD2B SLCO3A1 SLCO1B3 SLC35E2B SLCO1B1 SLC18B1 ABCA8 SLC47A2 SLCO5A1 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 SLC47A1 ABCD2 MFSD1 | 1.06e-16 | 477 | 110 | 24 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC2A8 SLCO2B1 SLC5A7 MFSD2B SLCO3A1 SLCO1B3 SLC35E2B SLCO1B1 SLC18B1 SLC47A2 SLCO5A1 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 SLC47A1 MFSD1 | 1.83e-16 | 296 | 110 | 20 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1S KCNV2 SLC5A7 SLC18B1 CHRNA1 SLC47A2 CHRNA3 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 SLC22A3 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 | 7.81e-11 | 664 | 110 | 21 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1S KCNV2 SLC5A7 SLC18B1 CHRNA1 SLC47A2 CHRNA3 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 SLC22A3 UCP3 SCN7A SLC6A5 APOL4 KCNN1 SLC47A1 | 3.15e-10 | 793 | 110 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1S KCNV2 SLC5A7 SLC18B1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 SLC22A3 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 | 1.42e-09 | 627 | 110 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1S KCNV2 SLC5A7 SLC18B1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 SLC22A3 UCP3 SCN7A SLC6A5 APOL4 KCNN1 SLC47A1 | 5.30e-09 | 758 | 110 | 20 | GO:0015318 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC2A8 SLCO2B1 SLCO3A1 SLCO1B3 SLCO1B1 SLCO5A1 SLC17A5 SLC22A14 SLC22A13 SLC22A3 SLC6A5 SLC47A1 ABCD2 | 8.34e-09 | 293 | 110 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1M1 MCHR1 TAS1R3 OR10J3 MRGPRF MCHR2 OR1C1 GPR162 PTGFR BDKRB2 OR1J2 OR3A2 TAS2R16 GPR174 P2RY1 P2RY4 OR1A1 OR1P1 GPR156 OR3A3 C3AR1 | 1.31e-08 | 884 | 110 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1M1 IL12RB2 MCHR1 TAS1R3 OR10J3 MRGPRF MCHR2 OR1C1 GPR162 PTGFR CHRNA1 CHRNA3 BDKRB2 OR1J2 OR3A2 TAS2R16 GPR174 P2RY1 P2RY4 SCN7A OR1A1 OR1P1 GPR156 OR3A3 C3AR1 MERTK | 1.49e-08 | 1353 | 110 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.89e-08 | 34 | 110 | 6 | GO:0042910 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 3.75e-08 | 18 | 110 | 5 | GO:0015347 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1S KCNV2 SLC5A7 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 SLC22A3 UCP3 SCN7A SLC6A5 KCNN1 | 3.99e-08 | 465 | 110 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 1.63e-07 | 3 | 110 | 3 | GO:0018858 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 4.17e-07 | 12 | 110 | 4 | GO:0008504 | |
| GeneOntologyMolecularFunction | monoamine:proton antiporter activity | 6.48e-07 | 4 | 110 | 3 | GO:0015311 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 6.48e-07 | 4 | 110 | 3 | GO:0102391 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 8.36e-07 | 14 | 110 | 4 | GO:0015132 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC5A7 SLC18B1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 SLC47A1 | 8.63e-07 | 301 | 110 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | antiporter activity | SLC35E2B SLC18B1 SLC47A2 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC47A1 | 9.61e-07 | 138 | 110 | 8 | GO:0015297 |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.14e-06 | 15 | 110 | 4 | GO:0071714 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCA12 SLCO2B1 MFSD2B SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 NPC1L1 ABCD2 | 1.39e-06 | 196 | 110 | 9 | GO:0005319 |
| GeneOntologyMolecularFunction | symporter activity | SLC5A7 MFSD2B SLC17A5 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 | 1.80e-06 | 150 | 110 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.40e-06 | 70 | 110 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.07e-06 | 73 | 110 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.79e-06 | 171 | 110 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 8.93e-06 | 8 | 110 | 3 | GO:0004321 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 9.61e-06 | 188 | 110 | 8 | GO:0015078 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLCO2B1 SLCO1B3 SLCO1B1 SLC17A5 SLC22A13 SLC6A5 SLC47A1 ABCD2 | 1.93e-05 | 207 | 110 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLCO2B1 SLCO1B3 SLCO1B1 SLC17A5 SLC22A13 SLC6A5 SLC47A1 ABCD2 | 2.00e-05 | 208 | 110 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1S KCNV2 CHRNA1 CHRNA3 SLC24A4 KCNC2 KCNC3 KCNC4 SCN7A KCNN1 | 2.01e-05 | 343 | 110 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 2.60e-05 | 11 | 110 | 3 | GO:0015203 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 2.60e-05 | 11 | 110 | 3 | GO:0031956 | |
| GeneOntologyMolecularFunction | polyspecific organic cation:proton antiporter activity | 3.01e-05 | 2 | 110 | 2 | GO:0140968 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.90e-05 | 167 | 110 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1S KCNV2 CHRNA1 CHRNA3 SLC24A4 KCNC2 KCNC3 KCNC4 SCN7A APOL4 KCNN1 | 4.63e-05 | 459 | 110 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.10e-05 | 119 | 110 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 8.30e-05 | 42 | 110 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 8.50e-05 | 81 | 110 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 8.65e-05 | 16 | 110 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | serotonin:sodium:chloride symporter activity | 8.99e-05 | 3 | 110 | 2 | GO:0005335 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 9.55e-05 | 83 | 110 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.71e-05 | 334 | 110 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.05e-04 | 17 | 110 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.40e-04 | 90 | 110 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.48e-04 | 19 | 110 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1S KCNV2 CHRNA1 CHRNA3 SLC24A4 KCNC2 KCNC3 KCNC4 SCN7A APOL4 KCNN1 | 1.53e-04 | 525 | 110 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.53e-04 | 49 | 110 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1S KCNV2 CHRNA1 CHRNA3 SLC24A4 KCNC2 KCNC3 KCNC4 SCN7A APOL4 KCNN1 | 1.55e-04 | 526 | 110 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.97e-04 | 152 | 110 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 2.01e-04 | 21 | 110 | 3 | GO:0016408 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 2.52e-04 | 102 | 110 | 5 | GO:0005249 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.66e-04 | 23 | 110 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 3.86e-04 | 26 | 110 | 3 | GO:0015645 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.86e-04 | 26 | 110 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 4.32e-04 | 27 | 110 | 3 | GO:0016405 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 4.82e-04 | 28 | 110 | 3 | GO:0005251 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 5.16e-04 | 182 | 110 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 5.47e-04 | 184 | 110 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 6.53e-04 | 31 | 110 | 3 | GO:0016878 | |
| GeneOntologyMolecularFunction | potassium channel activity | 7.16e-04 | 128 | 110 | 5 | GO:0005267 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 8.60e-04 | 34 | 110 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.02e-03 | 36 | 110 | 3 | GO:0090482 | |
| GeneOntologyMolecularFunction | uniporter activity | 1.31e-03 | 10 | 110 | 2 | GO:0015292 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 1.49e-03 | 41 | 110 | 3 | GO:0016877 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 1.60e-03 | 11 | 110 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 2.25e-03 | 13 | 110 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 2.25e-03 | 13 | 110 | 2 | GO:0045028 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 2.66e-03 | 431 | 110 | 8 | GO:0004984 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.01e-03 | 15 | 110 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.11e-03 | 109 | 110 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 3.87e-03 | 17 | 110 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.87e-03 | 17 | 110 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.84e-03 | 19 | 110 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.07e-03 | 125 | 110 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 6.46e-03 | 22 | 110 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 6.46e-03 | 22 | 110 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 6.87e-03 | 614 | 110 | 9 | GO:0140657 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1S MCHR1 SLCO2B1 KCNV2 SLC5A7 FXYD5 SLCO3A1 SLCO1B3 SLCO1B1 SLC18B1 CHRNA1 SLC47A2 CHRNA3 SLC17A5 SLC9A2 SLC24A4 KCNC2 P2RY1 KCNC3 KCNC4 P2RY4 SLC18A1 SLC18A2 SLC22A3 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 CCN2 | 3.62e-11 | 1374 | 113 | 30 | GO:0006811 |
| GeneOntologyBiologicalProcess | neurotransmitter transport | STXBP5L SLC5A7 SLC18B1 CHRNA3 SLC17A5 P2RY1 KCNC3 KCNC4 P2RY4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 MCTP2 | 1.55e-10 | 259 | 113 | 14 | GO:0006836 |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 1.30e-08 | 15 | 113 | 5 | GO:0043252 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 5.90e-08 | 64 | 113 | 7 | GO:0042908 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | STXBP5L CHRNA3 P2RY1 KCNC3 KCNC4 P2RY4 SLC18A1 SLC18A2 MCTP2 | 8.24e-08 | 141 | 113 | 9 | GO:0051588 |
| GeneOntologyBiologicalProcess | organic cation transport | SLC5A7 SLC18B1 SLC47A2 CHRNA3 P2RY1 SLC18A1 SLC22A3 SLC6A5 SLC47A1 | 1.05e-07 | 145 | 113 | 9 | GO:0015695 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1S MCHR1 KCNV2 SLC5A7 FXYD5 SLC18B1 CHRNA1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 CCN2 | 2.68e-07 | 1157 | 113 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR1M1 MCHR1 TAS1R3 OR10J3 MRGPRF MCHR2 MFSD2B OR1C1 PDE10A GPR162 PTGFR BDKRB2 OR1J2 OR3A2 TAS2R16 GPR174 SLC24A4 P2RY1 P2RY4 OR1A1 OR1P1 GPR156 OR3A3 C3AR1 | 4.36e-07 | 1395 | 113 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1S KCNV2 FXYD5 SLC18B1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 CCN2 | 5.97e-07 | 922 | 113 | 19 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1S KCNV2 FXYD5 SLC18B1 CHRNA1 SLC47A2 CHRNA3 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 CCN2 | 6.13e-07 | 1115 | 113 | 21 | GO:0034220 |
| GeneOntologyBiologicalProcess | serotonin uptake | 8.19e-07 | 14 | 113 | 4 | GO:0051610 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1S KCNV2 FXYD5 SLC18B1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 CCN2 | 8.24e-07 | 942 | 113 | 19 | GO:0098655 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC2A8 SLCO2B1 SLCO3A1 SLCO1B3 SLCO1B1 BDKRB2 SLCO5A1 SLC17A5 SLC22A14 SLC22A13 SLC22A3 SLC6A5 SLC47A1 ABCD2 | 8.77e-07 | 515 | 113 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 1.96e-06 | 38 | 113 | 5 | GO:0098810 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1S KCNV2 FXYD5 SLC18B1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SLC18A1 SLC18A2 UCP3 SCN7A SLC6A5 KCNN1 SLC47A1 CCN2 | 2.56e-06 | 1017 | 113 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | SLCO2B1 SLCO3A1 SLCO1B3 SLCO1B1 BDKRB2 SLC17A5 SLC22A13 SLC22A3 ABCD2 | 2.66e-06 | 213 | 113 | 9 | GO:0015718 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 3.92e-06 | 118 | 113 | 7 | GO:0046928 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | ABCA12 SLCO2B1 SLCO1B3 SLCO1B1 SLC18B1 ABCA8 P2RY1 SLC18A1 SLC18A2 SLC22A3 NPC1L1 | 4.43e-06 | 358 | 113 | 11 | GO:0015850 |
| GeneOntologyBiologicalProcess | proton transmembrane transport | 4.43e-06 | 170 | 113 | 8 | GO:1902600 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 9.56e-06 | 52 | 113 | 5 | GO:0001504 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLCO2B1 SLCO3A1 SLCO1B3 SLCO1B1 BDKRB2 SLC17A5 SLC22A13 SLC22A3 SLC6A5 SLC47A1 ABCD2 | 1.58e-05 | 410 | 113 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLCO2B1 SLCO3A1 SLCO1B3 SLCO1B1 BDKRB2 SLC17A5 SLC22A13 SLC22A3 SLC6A5 SLC47A1 ABCD2 | 1.66e-05 | 412 | 113 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | lipid transport | ABCA12 SLCO2B1 MFSD2B SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 BDKRB2 UCP3 NPC1L1 APOL4 ABCD2 | 2.18e-05 | 506 | 113 | 12 | GO:0006869 |
| GeneOntologyBiologicalProcess | neurotransmitter loading into synaptic vesicle | 2.56e-05 | 11 | 113 | 3 | GO:0098700 | |
| GeneOntologyBiologicalProcess | pigment catabolic process | 2.56e-05 | 11 | 113 | 3 | GO:0046149 | |
| GeneOntologyBiologicalProcess | heme catabolic process | 2.56e-05 | 11 | 113 | 3 | GO:0042167 | |
| GeneOntologyBiologicalProcess | serotonin transport | 2.73e-05 | 32 | 113 | 4 | GO:0006837 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 4.40e-05 | 13 | 113 | 3 | GO:0006787 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 5.58e-05 | 14 | 113 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | lipid localization | ABCA12 SLCO2B1 MFSD2B SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 BDKRB2 UCP3 NPC1L1 APOL4 ABCD2 | 6.35e-05 | 565 | 113 | 12 | GO:0010876 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR1M1 TAS1R3 OR10J3 OR1C1 OR1J2 OR3A2 TAS2R16 SLC24A4 OR1A1 OR1P1 OR3A3 | 7.29e-05 | 485 | 113 | 11 | GO:0050907 |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.01e-04 | 195 | 113 | 7 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.01e-04 | 195 | 113 | 7 | GO:0007269 | |
| GeneOntologyBiologicalProcess | polyamine transport | 1.03e-04 | 17 | 113 | 3 | GO:0015846 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 1.28e-04 | 272 | 113 | 8 | GO:0006813 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR1M1 TAS1R3 OR10J3 OR1C1 OR1J2 OR3A2 TAS2R16 SLC24A4 OR1A1 OR1P1 OR3A3 | 1.44e-04 | 524 | 113 | 11 | GO:0009593 |
| GeneOntologyBiologicalProcess | histamine uptake | 1.77e-04 | 4 | 113 | 2 | GO:0051615 | |
| GeneOntologyBiologicalProcess | aminergic neurotransmitter loading into synaptic vesicle | 1.77e-04 | 4 | 113 | 2 | GO:0015842 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR1M1 TAS1R3 OR10J3 OR1C1 OR1J2 OR3A2 TAS2R16 SLC24A4 OR1A1 OR1P1 OR3A3 | 2.09e-04 | 547 | 113 | 11 | GO:0007606 |
| GeneOntologyBiologicalProcess | vitamin transport | 2.52e-04 | 56 | 113 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | oligopeptide transport | 2.62e-04 | 23 | 113 | 3 | GO:0006857 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 2.93e-04 | 232 | 113 | 7 | GO:0071805 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR1M1 TAS1R3 OR10J3 OR1C1 OR1J2 OR3A2 TAS2R16 SLC24A4 OR1A1 OR1P1 OR3A3 | 3.55e-04 | 582 | 113 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | spermidine transport | 4.40e-04 | 6 | 113 | 2 | GO:0015848 | |
| GeneOntologyBiologicalProcess | monoamine transport | 4.47e-04 | 116 | 113 | 5 | GO:0015844 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 6.24e-04 | 432 | 113 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 6.34e-04 | 264 | 113 | 7 | GO:0099504 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 6.95e-04 | 73 | 113 | 4 | GO:0071715 | |
| GeneOntologyBiologicalProcess | fatty acid transport | 8.04e-04 | 132 | 113 | 5 | GO:0015908 | |
| GeneOntologyBiologicalProcess | positive regulation of G0 to G1 transition | 8.15e-04 | 8 | 113 | 2 | GO:0070318 | |
| GeneOntologyBiologicalProcess | action potential | 8.46e-04 | 201 | 113 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | prostaglandin transport | 8.47e-04 | 34 | 113 | 3 | GO:0015732 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 1.00e-03 | 36 | 113 | 3 | GO:0007274 | |
| GeneOntologyBiologicalProcess | norepinephrine uptake | 1.04e-03 | 9 | 113 | 2 | GO:0051620 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 1.05e-03 | 465 | 113 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 1.08e-03 | 289 | 113 | 7 | GO:0009636 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.08e-03 | 141 | 113 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1S MCHR1 KCNV2 SLC5A7 FXYD5 SLC9A2 SLC24A4 KCNC2 KCNC3 KCNC4 SCN7A SLC6A5 KCNN1 CCN2 | 1.14e-03 | 1000 | 113 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | norepinephrine transport | 1.17e-03 | 38 | 113 | 3 | GO:0015874 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.41e-03 | 222 | 113 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.48e-03 | 224 | 113 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | export from cell | ABCA12 STXBP5L SLC47A2 CHRNA3 SLC24A4 P2RY1 KCNC3 KCNC4 P2RY4 SLC18A1 SLC18A2 SLC47A1 CCN2 MERTK MCTP2 | 1.56e-03 | 1153 | 113 | 15 | GO:0140352 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | STXBP5L SLC5A7 CHRNA1 CHRNA3 P2RY1 KCNC3 KCNC4 P2RY4 SLC18A2 SLC6A5 KCNN1 MCTP2 CDH8 | 1.76e-03 | 931 | 113 | 13 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | STXBP5L SLC5A7 CHRNA1 CHRNA3 P2RY1 KCNC3 KCNC4 P2RY4 SLC18A2 SLC6A5 KCNN1 MCTP2 CDH8 | 1.76e-03 | 931 | 113 | 13 | GO:0007268 |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 1.80e-03 | 44 | 113 | 3 | GO:0007271 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLCO2B1 FXYD5 SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 SLCO5A1 SLC17A5 KCNC2 P2RY1 P2RY4 SLC22A3 SLC47A1 | 1.94e-08 | 320 | 113 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | SLCO2B1 FXYD5 SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 SLCO5A1 SLC17A5 KCNC2 P2RY1 P2RY4 SLC22A3 SLC47A1 | 6.33e-08 | 354 | 113 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | SLCO2B1 FXYD5 SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 SLCO5A1 SLC17A5 KCNC2 P2RY1 P2RY4 SLC22A3 SLC47A1 | 1.35e-07 | 378 | 113 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | apical plasma membrane | SLCO2B1 SLC5A7 SLCO3A1 SLC47A2 SLC9A2 SLC24A4 KCNC2 P2RY1 P2RY4 SLC22A13 SLC22A3 NPC1L1 SLC47A1 | 2.34e-06 | 487 | 113 | 13 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | SLCO2B1 SLC5A7 SLCO3A1 SLC47A2 SLC9A2 SLC24A4 KCNC2 P2RY1 P2RY4 SLC22A13 SLC22A3 NPC1L1 SLC47A1 | 1.90e-05 | 592 | 113 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | synaptic membrane | SLC5A7 ELFN2 CHRNA1 CHRNA3 KCNC2 P2RY1 KCNC3 KCNC4 P2RY4 SLC6A5 GPR156 CDH8 | 7.54e-05 | 583 | 113 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | presynapse | SLC2A8 SLC5A7 SLC18B1 SLC17A5 KCNC2 P2RY1 KCNC3 KCNC4 P2RY4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 MCTP2 CDH8 | 8.53e-05 | 886 | 113 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1S HLA-DMB KCNV2 CHRNA1 CHRNA3 KCNC2 KCNC3 KCNC4 SCN7A KCNN1 TRBV4-3 GPR156 TRBV4-2 CDH8 | 8.66e-05 | 785 | 113 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 1.36e-04 | 91 | 113 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.15e-04 | 378 | 113 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.28e-04 | 300 | 113 | 8 | GO:0008021 | |
| GeneOntologyCellularComponent | potassium channel complex | 2.54e-04 | 104 | 113 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | clathrin-sculpted monoamine transport vesicle | 2.87e-04 | 5 | 113 | 2 | GO:0070081 | |
| GeneOntologyCellularComponent | clathrin-sculpted monoamine transport vesicle membrane | 2.87e-04 | 5 | 113 | 2 | GO:0070083 | |
| GeneOntologyCellularComponent | cation channel complex | 2.92e-04 | 235 | 113 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | exocytic vesicle | 3.51e-04 | 320 | 113 | 8 | GO:0070382 | |
| GeneOntologyCellularComponent | neuromuscular junction | 3.58e-04 | 112 | 113 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 4.29e-04 | 179 | 113 | 6 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 4.29e-04 | 179 | 113 | 6 | GO:0030672 | |
| GeneOntologyCellularComponent | transport vesicle | CRISPLD2 SLC2A8 ABCA12 SLC5A7 SLC18B1 SLC17A5 KCNC4 SLC18A1 SLC18A2 MCTP2 | 5.16e-04 | 519 | 113 | 10 | GO:0030133 |
| GeneOntologyCellularComponent | presynaptic membrane | 7.77e-04 | 277 | 113 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | axon terminus | 9.91e-04 | 210 | 113 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.08e-03 | 293 | 113 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.62e-03 | 405 | 113 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 1.62e-03 | 43 | 113 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.69e-03 | 233 | 113 | 6 | GO:0044306 | |
| GeneOntologyCellularComponent | cell body membrane | 2.10e-03 | 47 | 113 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.14e-03 | 523 | 113 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 3.00e-03 | 550 | 113 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | clathrin-sculpted vesicle | 3.31e-03 | 16 | 113 | 2 | GO:0060198 | |
| GeneOntologyCellularComponent | dendrite membrane | 3.46e-03 | 56 | 113 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | dense core granule | 3.46e-03 | 56 | 113 | 3 | GO:0031045 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 4.19e-03 | 18 | 113 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | receptor complex | IL12RB2 TAS1R3 OLR1 CHRNA1 CHRNA3 TRBV4-3 GPR156 TRBV4-2 MERTK | 4.30e-03 | 581 | 113 | 9 | GO:0043235 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC2A8 HLA-DMB ABCA12 SLC5A7 IRAK2 SLC18B1 OLR1 SLC17A5 SPPL2A SLC18A1 SLC18A2 NPC1L1 C3AR1 MCTP2 PIP4P2 | 4.53e-03 | 1307 | 113 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | SLC2A8 HLA-DMB ABCA12 SLC5A7 IRAK2 SLC18B1 OLR1 SLC17A5 SPPL2A SLC18A1 SLC18A2 NPC1L1 C3AR1 MCTP2 PIP4P2 | 5.13e-03 | 1325 | 113 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | glycinergic synapse | 5.16e-03 | 20 | 113 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | axolemma | 5.69e-03 | 21 | 113 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 6.23e-03 | 22 | 113 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1S HLA-DMB STXBP5L KCNV2 CHRNA1 CHRNA3 LRRN3 KCNC2 KCNC3 KCNC4 SCN7A KCNN1 TRBV4-3 GPR156 TRBV4-2 CDH8 | 6.69e-03 | 1498 | 113 | 16 | GO:0098796 |
| GeneOntologyCellularComponent | secretory vesicle | CRISPLD2 SLC2A8 ABCA12 STXBP5L SLC5A7 SLC18B1 OLR1 SLC17A5 KCNC4 SLC18A1 SLC18A2 SLC6A5 C3AR1 MCTP2 | 7.29e-03 | 1246 | 113 | 14 | GO:0099503 |
| Domain | MFS_dom | SLC2A8 SLCO2B1 MFSD2B SLCO3A1 SLCO1B3 SLCO1B1 SLC18B1 SLCO5A1 SLC17A5 SLC18A1 SLC18A2 SLC22A14 SLC22A13 SLC22A3 MFSD1 | 1.53e-15 | 134 | 108 | 15 | IPR020846 |
| Domain | MFS | SLC2A8 MFSD2B SLCO1B3 SLCO1B1 SLC18B1 SLCO5A1 SLC17A5 SLC18A1 SLC18A2 SLC22A14 SLC22A13 SLC22A3 MFSD1 | 5.02e-14 | 108 | 108 | 13 | PS50850 |
| Domain | OA_transporter | 4.52e-09 | 12 | 108 | 5 | IPR004156 | |
| Domain | OATP | 4.52e-09 | 12 | 108 | 5 | PF03137 | |
| Domain | MFS_1 | SLC18B1 SLC17A5 SLC18A1 SLC18A2 SLC22A14 SLC22A13 SLC22A3 MFSD1 | 1.45e-08 | 77 | 108 | 8 | PF07690 |
| Domain | MFS | SLC18B1 SLC17A5 SLC18A1 SLC18A2 SLC22A14 SLC22A13 SLC22A3 MFSD1 | 1.45e-08 | 77 | 108 | 8 | IPR011701 |
| Domain | GPCR_Rhodpsn_7TM | OR1M1 MCHR1 OR10J3 MRGPRF MCHR2 OR1C1 GPR162 PTGFR BDKRB2 OR1J2 OR3A2 GPR174 P2RY1 P2RY4 OR1A1 OR3A3 C3AR1 | 2.89e-07 | 670 | 108 | 17 | IPR017452 |
| Domain | 7tm_1 | OR1M1 MCHR1 OR10J3 MRGPRF MCHR2 OR1C1 GPR162 PTGFR BDKRB2 OR1J2 OR3A2 GPR174 P2RY1 P2RY4 OR1A1 OR3A3 C3AR1 | 3.35e-07 | 677 | 108 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR1M1 MCHR1 OR10J3 MRGPRF MCHR2 OR1C1 GPR162 PTGFR BDKRB2 OR1J2 OR3A2 GPR174 P2RY1 P2RY4 OR1A1 OR3A3 C3AR1 | 3.94e-07 | 685 | 108 | 17 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR1M1 MCHR1 OR10J3 MRGPRF MCHR2 OR1C1 GPR162 PTGFR BDKRB2 OR1J2 OR3A2 GPR174 P2RY1 P2RY4 OR1A1 OR3A3 C3AR1 | 4.45e-07 | 691 | 108 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | OR1M1 MCHR1 OR10J3 MRGPRF MCHR2 OR1C1 GPR162 PTGFR BDKRB2 OR1J2 OR3A2 GPR174 P2RY1 P2RY4 OR1A1 OR3A3 C3AR1 | 4.54e-07 | 692 | 108 | 17 | IPR000276 |
| Domain | K_chnl_volt-dep_Kv3 | 7.49e-07 | 4 | 108 | 3 | IPR003974 | |
| Domain | Channel_four-helix_dom | 9.28e-07 | 57 | 108 | 6 | IPR027359 | |
| Domain | - | 9.28e-07 | 57 | 108 | 6 | 1.20.120.350 | |
| Domain | KAZAL_2 | 1.01e-05 | 50 | 108 | 5 | PS51465 | |
| Domain | Kazal_dom | 1.12e-05 | 51 | 108 | 5 | IPR002350 | |
| Domain | K_chnl_volt-dep_Kv | 1.67e-05 | 27 | 108 | 4 | IPR003968 | |
| Domain | Potassium_chann | 3.31e-05 | 2 | 108 | 2 | PF11404 | |
| Domain | MATE_fam | 3.31e-05 | 2 | 108 | 2 | IPR002528 | |
| Domain | MCH_rcpt | 3.31e-05 | 2 | 108 | 2 | IPR008361 | |
| Domain | K_chnl_volt-dep_Kv3_ID | 3.31e-05 | 2 | 108 | 2 | IPR021105 | |
| Domain | MatE | 3.31e-05 | 2 | 108 | 2 | PF01554 | |
| Domain | VG_K_chnl | 3.80e-05 | 33 | 108 | 4 | IPR028325 | |
| Domain | Ion_trans_dom | 5.23e-05 | 114 | 108 | 6 | IPR005821 | |
| Domain | Ion_trans | 5.23e-05 | 114 | 108 | 6 | PF00520 | |
| Domain | Kazal_2 | 5.40e-05 | 36 | 108 | 4 | PF07648 | |
| Domain | AMP-bd_C | 1.21e-04 | 17 | 108 | 3 | IPR025110 | |
| Domain | AMP-binding_C | 1.21e-04 | 17 | 108 | 3 | PF13193 | |
| Domain | KAZAL | 1.43e-04 | 46 | 108 | 4 | SM00280 | |
| Domain | ABC_tran | 1.69e-04 | 48 | 108 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.69e-04 | 48 | 108 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.83e-04 | 49 | 108 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.98e-04 | 50 | 108 | 4 | IPR003439 | |
| Domain | BTB_2 | 2.49e-04 | 53 | 108 | 4 | PF02214 | |
| Domain | T1-type_BTB | 2.49e-04 | 53 | 108 | 4 | IPR003131 | |
| Domain | TDE1/TMS | 3.28e-04 | 5 | 108 | 2 | IPR005016 | |
| Domain | Serinc | 3.28e-04 | 5 | 108 | 2 | PF03348 | |
| Domain | AMP-binding_CS | 4.44e-04 | 26 | 108 | 3 | IPR020845 | |
| Domain | AMP_BINDING | 5.54e-04 | 28 | 108 | 3 | PS00455 | |
| Domain | AMP-binding | 6.81e-04 | 30 | 108 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 6.81e-04 | 30 | 108 | 3 | IPR000873 | |
| Domain | Ptc/Disp | 1.16e-03 | 9 | 108 | 2 | IPR003392 | |
| Domain | Patched | 1.16e-03 | 9 | 108 | 2 | PF02460 | |
| Domain | MFS_sugar_transport-like | 1.17e-03 | 36 | 108 | 3 | IPR005828 | |
| Domain | Sugar_tr | 1.17e-03 | 36 | 108 | 3 | PF00083 | |
| Domain | ABC_transporter_CS | 1.83e-03 | 42 | 108 | 3 | IPR017871 | |
| Domain | ABC_A | 2.11e-03 | 12 | 108 | 2 | IPR026082 | |
| Domain | SSD | 2.48e-03 | 13 | 108 | 2 | IPR000731 | |
| Domain | SSD | 2.48e-03 | 13 | 108 | 2 | PS50156 | |
| Domain | Nicotinic_acetylcholine_rcpt | 3.77e-03 | 16 | 108 | 2 | IPR002394 | |
| Domain | SUGAR_TRANSPORT_2 | 4.26e-03 | 17 | 108 | 2 | PS00217 | |
| Domain | ADH_SF_Zn-type | 5.31e-03 | 19 | 108 | 2 | IPR002085 | |
| Domain | GPCR_3 | 6.48e-03 | 21 | 108 | 2 | IPR000337 | |
| Domain | 7tm_3 | 7.10e-03 | 22 | 108 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 7.10e-03 | 22 | 108 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 7.10e-03 | 22 | 108 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 7.10e-03 | 22 | 108 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 7.10e-03 | 22 | 108 | 2 | PS50259 | |
| Domain | GPCR_3_C | 7.10e-03 | 22 | 108 | 2 | IPR017978 | |
| Domain | - | 7.74e-03 | 23 | 108 | 2 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 7.74e-03 | 23 | 108 | 2 | IPR027361 | |
| Domain | Olfact_rcpt | 7.85e-03 | 393 | 108 | 7 | IPR000725 | |
| Domain | SUGAR_TRANSPORT_1 | 8.42e-03 | 24 | 108 | 2 | PS00216 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A8 SLCO2B1 SLC5A7 SLCO3A1 SLCO1B3 SLCO1B1 SLC47A2 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 SLC47A1 | 3.98e-11 | 249 | 89 | 15 | M5988 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A8 SLCO2B1 SLC5A7 SLCO3A1 SLCO1B3 SLCO1B1 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 SLC47A1 | 2.59e-10 | 238 | 89 | 14 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC2A8 ABCA12 SLCO2B1 ABCB5 SLC5A7 SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 SLC47A2 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 SLC47A1 ABCD2 | 1.23e-07 | 736 | 89 | 19 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC2A8 ABCA12 SLCO2B1 ABCB5 SLC5A7 SLCO3A1 SLCO1B3 SLCO1B1 ABCA8 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A3 SLC6A5 SLC47A1 ABCD2 | 1.98e-07 | 681 | 89 | 18 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 4.74e-07 | 11 | 89 | 4 | M930 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | MCHR1 OR1C1 PTGFR BDKRB2 OR3A2 GPR174 P2RY1 P2RY4 OR1A1 OR3A3 C3AR1 | 6.97e-07 | 260 | 89 | 11 | M39397 |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 7.07e-07 | 12 | 89 | 4 | MM15476 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 9.61e-07 | 84 | 89 | 7 | M27334 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | MCHR1 MCHR2 PTGFR CHRNA1 CHRNA3 BDKRB2 P2RY1 P2RY4 GPR156 C3AR1 | 8.06e-06 | 272 | 89 | 10 | M13380 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 8.19e-06 | 76 | 89 | 6 | MM15072 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 8.36e-06 | 7 | 89 | 3 | MM14598 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.99e-05 | 9 | 89 | 3 | M45020 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 1.99e-05 | 9 | 89 | 3 | M26968 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 3.74e-05 | 99 | 89 | 6 | M27474 | |
| Pathway | REACTOME_DRUG_ADME | 6.42e-05 | 109 | 89 | 6 | M45012 | |
| Pathway | WP_SULFATASE_AND_AROMATASE_PATHWAY | 8.42e-05 | 14 | 89 | 3 | M48085 | |
| Pathway | REACTOME_DRUG_ADME | 1.05e-04 | 119 | 89 | 6 | MM15692 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.05e-04 | 15 | 89 | 3 | M27060 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.05e-04 | 15 | 89 | 3 | MM15697 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.26e-04 | 41 | 89 | 4 | MM15075 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.26e-04 | 41 | 89 | 4 | MM14546 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.27e-04 | 177 | 89 | 7 | M27476 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.52e-04 | 43 | 89 | 4 | M1056 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.52e-04 | 43 | 89 | 4 | M881 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.66e-04 | 44 | 89 | 4 | M11911 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.19e-04 | 19 | 89 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 2.19e-04 | 19 | 89 | 3 | MM15107 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.57e-04 | 20 | 89 | 3 | MM14721 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.60e-04 | 335 | 89 | 9 | MM14503 | |
| Pathway | WP_GPCRS_NONODORANT | 2.73e-04 | 266 | 89 | 8 | MM15843 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 3.83e-04 | 98 | 89 | 5 | MM14545 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 4.82e-04 | 103 | 89 | 5 | M1073 | |
| Pathway | REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE | 5.82e-04 | 6 | 89 | 2 | MM14693 | |
| Pathway | REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE | 5.82e-04 | 6 | 89 | 2 | M27037 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 6.38e-04 | 27 | 89 | 3 | M1088 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.06e-03 | 32 | 89 | 3 | MM14719 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.13e-03 | 411 | 89 | 9 | M735 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 1.38e-03 | 9 | 89 | 2 | M27959 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.38e-03 | 9 | 89 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.38e-03 | 9 | 89 | 2 | MM15313 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 1.38e-03 | 9 | 89 | 2 | MM15707 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 2.09e-03 | 11 | 89 | 2 | M39422 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 2.09e-03 | 11 | 89 | 2 | MM15049 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.09e-03 | 11 | 89 | 2 | M883 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR1M1 TAS1R3 OR10J3 RBP3 OR1C1 OR1J2 OR3A2 TAS2R16 OR1A1 OR1P1 OR3A3 | 2.15e-03 | 636 | 89 | 11 | M41834 |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.50e-03 | 12 | 89 | 2 | M48008 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 2.50e-03 | 12 | 89 | 2 | M10960 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.50e-03 | 12 | 89 | 2 | MM15312 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 2.50e-03 | 12 | 89 | 2 | MM15953 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 2.50e-03 | 12 | 89 | 2 | M48096 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.55e-03 | 463 | 89 | 9 | M507 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.67e-03 | 44 | 89 | 3 | M45014 | |
| Pathway | WP_GPCRS_OTHER | 2.83e-03 | 93 | 89 | 4 | M39629 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.85e-03 | 45 | 89 | 3 | MM15694 | |
| Pathway | WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS | 2.94e-03 | 13 | 89 | 2 | M45518 | |
| Pathway | WP_GPCRS_ODORANT | 3.15e-03 | 157 | 89 | 5 | MM15872 | |
| Pathway | WP_GPCRS_OTHER | 3.17e-03 | 96 | 89 | 4 | MM15939 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 3.41e-03 | 14 | 89 | 2 | M757 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.54e-03 | 99 | 89 | 4 | MM14986 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 3.69e-03 | 314 | 89 | 7 | M600 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 3.92e-03 | 15 | 89 | 2 | MM14704 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 4.07e-03 | 51 | 89 | 3 | M39457 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.08e-03 | 103 | 89 | 4 | M758 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 4.47e-03 | 16 | 89 | 2 | M6786 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 4.47e-03 | 16 | 89 | 2 | MM15050 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 4.79e-03 | 417 | 89 | 8 | M4072 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.83e-03 | 330 | 89 | 7 | M18334 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 5.04e-03 | 17 | 89 | 2 | MM14552 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 5.65e-03 | 18 | 89 | 2 | M4862 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 5.65e-03 | 18 | 89 | 2 | M524 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 5.75e-03 | 430 | 89 | 8 | MM15160 | |
| Pubmed | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 2.11e-09 | 66 | 113 | 7 | 20679960 | |
| Pubmed | Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. | 7.32e-09 | 8 | 113 | 4 | 19129463 | |
| Pubmed | SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk. | 3.34e-08 | 3 | 113 | 3 | 24762081 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 1740329 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 28013215 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 21278488 | ||
| Pubmed | Impact of regulatory polymorphisms in organic anion transporter genes in the human liver. | 3.34e-08 | 3 | 113 | 3 | 19620935 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 29422623 | ||
| Pubmed | Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. | 3.34e-08 | 3 | 113 | 3 | 26383540 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 32587096 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 26409184 | ||
| Pubmed | 3.43e-08 | 11 | 113 | 4 | 14579113 | ||
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 21912965 | ||
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 17906856 | ||
| Pubmed | 1.33e-07 | 4 | 113 | 3 | 21849517 | ||
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 1.87e-07 | 16 | 113 | 4 | 35307651 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 1.87e-07 | 16 | 113 | 4 | 10673334 | |
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 10873595 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 20635135 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.80e-07 | 139 | 113 | 7 | 16985003 | |
| Pubmed | 6.33e-06 | 212 | 113 | 7 | 19521566 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 7.82e-06 | 219 | 113 | 7 | 12213199 | |
| Pubmed | 8.82e-06 | 40 | 113 | 4 | 16382104 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18314419 | ||
| Pubmed | OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. | 1.05e-05 | 2 | 113 | 2 | 21691816 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16521160 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19186169 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20047987 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10434065 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15610163 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28063966 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28493059 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12871984 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22240838 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29944058 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17412826 | ||
| Pubmed | SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome. | 1.05e-05 | 2 | 113 | 2 | 36964102 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 37856781 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21266523 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30433870 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12130747 | ||
| Pubmed | Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide. | 1.05e-05 | 2 | 113 | 2 | 23340295 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16162937 | ||
| Pubmed | A human transporter protein that mediates the final excretion step for toxic organic cations. | 1.05e-05 | 2 | 113 | 2 | 16330770 | |
| Pubmed | Identification and characterization of single-nucleotide polymorphisms in MCH-R1 and MCH-R2. | 1.05e-05 | 2 | 113 | 2 | 15340116 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29777022 | ||
| Pubmed | Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis. | 1.05e-05 | 2 | 113 | 2 | 26191226 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22771883 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24194513 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 18180273 | ||
| Pubmed | Chromosomal localization of the human vesicular amine transporter genes. | 1.05e-05 | 2 | 113 | 2 | 7905859 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19634011 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23303678 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20067714 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 37723174 | ||
| Pubmed | Rapid Regulation of Human Multidrug and Extrusion Transporters hMATE1 and hMATE2K. | 1.05e-05 | 2 | 113 | 2 | 32708212 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24855184 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15941924 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26474710 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25578040 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20016398 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28815335 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 10072596 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29948332 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23670789 | ||
| Pubmed | The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. | 1.05e-05 | 2 | 113 | 2 | 16996621 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21606417 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24989890 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23267855 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17496208 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 11431013 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23236639 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26338179 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25920679 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35524772 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 27098745 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24740327 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21719246 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20877131 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 8643547 | ||
| Pubmed | SVK14 cells express an MCH binding site different from the MCH1 or MCH2 receptor. | 1.05e-05 | 2 | 113 | 2 | 12127971 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 27271370 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19158817 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16534140 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31299240 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23886114 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17509534 | ||
| Pubmed | OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture. | 1.05e-05 | 2 | 113 | 2 | 21787759 | |
| Pubmed | Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. | 1.05e-05 | 2 | 113 | 2 | 18321482 | |
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 2.63e-05 | 18 | 113 | 3 | 23696569 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19010884 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 31047942 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 26146841 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 22673617 | ||
| Pubmed | Purinergic receptors expressed in human skeletal muscle fibres. | 3.13e-05 | 3 | 113 | 2 | 22052557 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 18296417 | ||
| Pubmed | Identification and characterization of a melanin-concentrating hormone receptor. | 3.13e-05 | 3 | 113 | 2 | 11416225 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 30955241 | ||
| Pubmed | Autocrine and paracrine roles for ATP and serotonin in mouse taste buds. | 3.13e-05 | 3 | 113 | 2 | 19890001 | |
| Pubmed | Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations. | 3.13e-05 | 3 | 113 | 2 | 20660695 | |
| Interaction | KCNC1 interactions | 1.03e-06 | 16 | 101 | 4 | int:KCNC1 | |
| Cytoband | 17p13.3 | 6.92e-05 | 88 | 113 | 4 | 17p13.3 | |
| Cytoband | 16p12.3 | 8.22e-05 | 34 | 113 | 3 | 16p12.3 | |
| GeneFamily | Solute carriers | SLC2A8 SLCO2B1 SLC5A7 SLCO3A1 SLCO1B3 SLC35E2B SLCO1B1 SLC18B1 SLC47A2 SLCO5A1 SLC17A5 SLC9A2 SLC24A4 SLC18A1 SLC18A2 SLC22A14 SLC22A13 SLC22A3 UCP3 SLC6A5 SLC47A1 | 1.60e-16 | 395 | 87 | 21 | 752 |
| GeneFamily | Olfactory receptors, family 1 | 1.32e-06 | 40 | 87 | 5 | 147 | |
| GeneFamily | Melanin concentrating hormone receptors | 2.29e-05 | 2 | 87 | 2 | 235 | |
| GeneFamily | Potassium voltage-gated channels | 4.00e-05 | 40 | 87 | 4 | 274 | |
| GeneFamily | Acyl-CoA synthetase family | 2.58e-04 | 26 | 87 | 3 | 40 | |
| GeneFamily | Olfactory receptors, family 3 | 3.39e-04 | 6 | 87 | 2 | 150 | |
| GeneFamily | Purinergic receptors P2Y | 1.00e-03 | 10 | 87 | 2 | 213 | |
| GeneFamily | ATP binding cassette subfamily A | 2.01e-03 | 14 | 87 | 2 | 805 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.63e-03 | 16 | 87 | 2 | 173 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 6.31e-03 | 78 | 87 | 3 | 262 | |
| GeneFamily | Fibronectin type III domain containing | 7.44e-03 | 160 | 87 | 4 | 555 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP | 2.41e-06 | 200 | 112 | 8 | M7471 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-08 | 198 | 112 | 8 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-08 | 76 | 112 | 6 | 98271aadf026a01bf933f8279d11a0413e47d549 | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.73e-07 | 192 | 112 | 7 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.36e-07 | 195 | 112 | 7 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 7.29e-07 | 199 | 112 | 7 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | 54167894a16e975d0541cbe3e515bcfa183044f6 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-07 | 199 | 112 | 7 | a4785c1921a3de18a9190e4d674ede6a90f80004 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | b818d46a39c8782188d82dc8931b8eec9d549dd1 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 77 | 112 | 5 | 557f7518e9a89d99f3f2474720deb9cde10e1054 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 80 | 112 | 5 | 6720438bf51831e98402a700dfc25bd57e0c6798 | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-06 | 145 | 112 | 6 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-06 | 150 | 112 | 6 | 909ccab92855f5f049dc29593aadab1ea973297b | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 152 | 112 | 6 | 0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-06 | 153 | 112 | 6 | c81a88d3f707487c511020d3960a1c41e706c6a0 | |
| ToppCell | facs-SCAT-Fat-18m-Epithelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 162 | 112 | 6 | 341fa357ad7bdbef30864e8062f161e60185ffc9 | |
| ToppCell | facs-SCAT-Fat-18m-Epithelial-epithelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 162 | 112 | 6 | 7215f6eb2b65dea455e2eec722a9c38e6958b120 | |
| ToppCell | facs-SCAT-Fat-18m-Epithelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 162 | 112 | 6 | 7fa93efa2039d68a4e8214fa143bcd3368349a2d | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 3.99e-06 | 166 | 112 | 6 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.40e-06 | 175 | 112 | 6 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.40e-06 | 175 | 112 | 6 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_straight_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-06 | 180 | 112 | 6 | b34d933cdabf692f02eaaf65c2aaca1fb9510627 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-06 | 180 | 112 | 6 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-06 | 181 | 112 | 6 | 42f5a645beeb5a1a746d79ea7fe7fd3786fd35ad | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-06 | 181 | 112 | 6 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.20e-06 | 184 | 112 | 6 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 7c256bcfa07c5ff55aad0833e8712b0456b5832b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 184 | 112 | 6 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-06 | 185 | 112 | 6 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-06 | 185 | 112 | 6 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-06 | 186 | 112 | 6 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.14e-06 | 188 | 112 | 6 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-06 | 190 | 112 | 6 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.91e-06 | 191 | 112 | 6 | 94c7da03e5264f4d73bb507ce339a935d90279a0 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.91e-06 | 191 | 112 | 6 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.91e-06 | 191 | 112 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.18e-06 | 192 | 112 | 6 | 22f335e6e75a694cdccafe189b5ee7815ef28c03 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-06 | 192 | 112 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 9.18e-06 | 192 | 112 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-06 | 192 | 112 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 9.46e-06 | 193 | 112 | 6 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.46e-06 | 193 | 112 | 6 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.46e-06 | 193 | 112 | 6 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 9.74e-06 | 194 | 112 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.74e-06 | 194 | 112 | 6 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.74e-06 | 194 | 112 | 6 | 8e2819a9d0529f7b2de1a7c1190575175d6173ee | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 9.74e-06 | 194 | 112 | 6 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-06 | 194 | 112 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-05 | 195 | 112 | 6 | 704a12ac0c71af4a9cfb2473490b9a7c05dc42d7 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-05 | 195 | 112 | 6 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.00e-05 | 195 | 112 | 6 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | 367C-Myeloid-Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-05 | 195 | 112 | 6 | 77cd831a5da5ab1751499db541f318faf925e527 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-05 | 195 | 112 | 6 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-05 | 195 | 112 | 6 | eb104f3bb08ab9eca31273c0523a5c90de1f30a9 | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.03e-05 | 196 | 112 | 6 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.06e-05 | 197 | 112 | 6 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-05 | 197 | 112 | 6 | 72775eb6c24cfb956436642ac9cd6e4d5c01ea5f | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-05 | 197 | 112 | 6 | 3b859c3bbb71858b97ce670bd507e67c377b88eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 112 | 6 | fa5c15a656d4132950092919600e270f1fd79abf | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 112 | 6 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 198 | 112 | 6 | 436f3a9ef31b0991765bb97c21960f20fa71d578 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.13e-05 | 199 | 112 | 6 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 98c0d57c247d39bc771d81f4387f8dd01222628e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 199 | 112 | 6 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | ea039de8bd8b325845ce361f84e600c6dad922ed | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | eac46978e2b3d38cf42b44f7b0350d0489d036b3 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.16e-05 | 200 | 112 | 6 | 33c5615cbedb9e14f4433169babd3a3a51f69b4c | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-MoAM-MoAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 200 | 112 | 6 | baef622b82b262609cf5410f701ac814c20c3557 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 1a080564de59abd59d3208a73441b6346e1c7cd8 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-MoAM-MoAM-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 200 | 112 | 6 | 2e7478ddb2f09b0a14635759033c2e675b981c9f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 6e50272d172b491200d9a255ed08e6d6998cfe02 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.16e-05 | 200 | 112 | 6 | b3f4eb45545f1632dc62f942756a6b81397c18c1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 840be665639a53ba9bafc19f7a81ca1e0436e329 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-05 | 200 | 112 | 6 | 670ef1e68be0d2c6ea20ab4dea1d051a3cc89799 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 200 | 112 | 6 | 37a091925b214a0befea59b711ab92809a7b93c8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | 35951db6a4f442ac9e13f1b8cc5b4a33481f92c8 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | c210b98a75ab5d899d7278bc9b577f76a0b3970c | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 77a68e8fd97a3f3467d25032067fd7ad52ab8522 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 3cfb28299a55fc1c150262a7333c59a48ae65ad1 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-MoAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 200 | 112 | 6 | b66bd4904dd577748156665bc5b701a3ad55d18c | |
| ToppCell | metastatic_Brain-Myeloid_cells-mo-Mac|metastatic_Brain / Location, Cell class and cell subclass | 1.16e-05 | 200 | 112 | 6 | 8f702d518f652782b0dd6ca3bdd965a79deb61f3 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 2d2835f97e0ff4f99d384f18e10876575f6bdefd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-05 | 200 | 112 | 6 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-05 | 118 | 112 | 5 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-05 | 118 | 112 | 5 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-05 | 118 | 112 | 5 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-05 | 118 | 112 | 5 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 1.27e-05 | 119 | 112 | 5 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | Control-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 1.33e-05 | 120 | 112 | 5 | 840d0ac995e2fa41996514753e4e03c4aa4a26d0 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 129 | 112 | 5 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.51e-05 | 137 | 112 | 5 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | TCGA-Bile_Duct-Solid_Tissue_Normal|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.79e-05 | 140 | 112 | 5 | 2c35c7d8b7e1101d1b74d7ce3da2364c5602c846 | |
| ToppCell | TCGA-Bile_Duct-Solid_Tissue_Normal-Bile_duct_normal_tissue-Bile_duct_normal_tissue|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.79e-05 | 140 | 112 | 5 | deb9d97f1260fe1c4ad4ec3e1ecb111d79f13058 | |
| Computational | Porins / transporters. | 1.04e-04 | 211 | 56 | 7 | MODULE_63 | |
| Drug | verapamil | CACNA1S ABCA12 KCNV2 ABCB5 SLCO1B1 CHRNA1 ABCA8 CHRNA3 KCNC2 KCNC3 KCNC4 SLC22A3 SCN7A KCNN1 ABCD2 ALPL | 1.81e-09 | 490 | 110 | 16 | CID000002520 |
| Drug | sodium | CACNA1S MCHR1 SLC2A8 HLA-DMB SLCO2B1 SLC5A7 SLCO3A1 SLCO1B3 SLCO1B1 CHRNA3 SLC9A2 SLC24A4 KCNC4 SLC18A1 SLC18A2 SLC22A3 SCN7A SLC6A5 KCNN1 SLC47A1 MERTK | 4.25e-09 | 944 | 110 | 21 | CID000000923 |
| Drug | probenecid | SLCO2B1 ABCB5 SLCO3A1 SLCO1B3 SLCO1B1 SLC47A2 SLC17A5 SLC22A13 SLC47A1 | 8.56e-09 | 123 | 110 | 9 | CID000004911 |
| Drug | cimetidine | SLCO2B1 ABCB5 SLCO3A1 SLCO1B3 SLCO1B1 SLC47A2 SLC17A5 SLC22A13 SLC22A3 SLC47A1 | 1.67e-08 | 179 | 110 | 10 | CID000002756 |
| Drug | hemicholinium-3 | 1.01e-07 | 78 | 110 | 7 | CID000003585 | |
| Drug | tetraethylammonium | CACNA1S ABCB5 ABCA8 KCNC2 KCNC3 KCNC4 SLC22A3 KCNN1 SLC47A1 ALPL | 2.24e-07 | 236 | 110 | 10 | CID000005413 |
| Drug | NSC 117356 | SLCO2B1 RRM2B ABCB5 SLC5A7 SLCO3A1 SLCO1B3 SLCO1B1 SLC17A5 SLC22A13 MERTK | 3.29e-07 | 246 | 110 | 10 | CID000004112 |
| Drug | 17beta-estradiol glucuronide | 4.36e-07 | 32 | 110 | 5 | CID000066424 | |
| Drug | Dihydromicrocystin Lr | 4.37e-07 | 4 | 110 | 3 | CID006441227 | |
| Drug | sulfobromophthalein | 6.86e-07 | 103 | 110 | 7 | CID000005345 | |
| Drug | Tetraethylammonium | 8.98e-07 | 16 | 110 | 4 | ctd:D019789 | |
| Drug | 2,2',4,4',5,6'-hexabromodiphenyl ether | 1.09e-06 | 5 | 110 | 3 | ctd:C555859 | |
| Drug | quindine | ABCB5 SLCO1B1 CHRNA1 CHRNA3 KCNC2 SLC22A3 SCN7A KCNN1 SLC47A1 | 1.20e-06 | 219 | 110 | 9 | CID000001065 |
| Drug | conta-1(35),3,5,7(37),8,10,12,15,32(36),33-decaene-30-carboxylic acid | 1.34e-06 | 72 | 110 | 6 | CID000489933 | |
| Drug | fexofenadine | 1.45e-06 | 73 | 110 | 6 | CID000003348 | |
| Drug | AC1NSKDT | 1.99e-06 | 77 | 110 | 6 | CID005311297 | |
| Drug | prednisolone phosphate | 2.17e-06 | 6 | 110 | 3 | CID000004896 | |
| Drug | Protons | 2.90e-06 | 21 | 110 | 4 | ctd:D011522 | |
| Drug | AC1L194J | 2.90e-06 | 21 | 110 | 4 | CID000000387 | |
| Drug | amiloride | CACNA1S CHRNA1 SLC47A2 CHRNA3 SLC9A2 SLC24A4 SLC18A1 SLC18A2 KCNN1 SLC47A1 | 3.08e-06 | 315 | 110 | 10 | CID000016230 |
| Drug | nateglinide | 3.79e-06 | 7 | 110 | 3 | ctd:C060142 | |
| Drug | sulfinpyrazone | 4.07e-06 | 87 | 110 | 6 | CID000005342 | |
| Drug | estrone sulfate | 4.25e-06 | 23 | 110 | 4 | ctd:C017296 | |
| Drug | NSC263652 | 6.04e-06 | 8 | 110 | 3 | CID000429721 | |
| Drug | Guanidine | 6.04e-06 | 8 | 110 | 3 | ctd:D019791 | |
| Drug | 1-methyl-4-phenylpyridinium | 6.46e-06 | 144 | 110 | 7 | CID000039484 | |
| Drug | AC1L19DA | 7.10e-06 | 26 | 110 | 4 | CID000000497 | |
| Drug | Chloramphenicol | 8.31e-06 | 27 | 110 | 4 | ctd:D002701 | |
| Drug | tariquidar | 8.31e-06 | 27 | 110 | 4 | CID000148201 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 9.02e-06 | 9 | 110 | 3 | ctd:C000588958 | |
| Drug | NSC740136 | 1.50e-05 | 109 | 110 | 6 | CID000003706 | |
| Drug | repaglinide | 1.76e-05 | 11 | 110 | 3 | ctd:C072379 | |
| Drug | Trimethoprim | 1.76e-05 | 11 | 110 | 3 | ctd:D014295 | |
| Drug | GBR 12909 | 2.11e-05 | 69 | 110 | 5 | CID000003455 | |
| Drug | l-Lobeline | 2.14e-05 | 34 | 110 | 4 | CID000003945 | |
| Drug | Digocin | 2.26e-05 | 70 | 110 | 5 | CID000003062 | |
| Drug | cinchonidine | 2.31e-05 | 2 | 110 | 2 | ctd:C041622 | |
| Drug | reserpic acid | 2.31e-05 | 2 | 110 | 2 | CID000065747 | |
| Drug | ethohexadiol | 2.31e-05 | 2 | 110 | 2 | ctd:C004917 | |
| Drug | azidoiodoketanserin | 2.31e-05 | 2 | 110 | 2 | CID003037022 | |
| Drug | methylcyclohexenone | 2.31e-05 | 2 | 110 | 2 | CID000014511 | |
| Drug | methyl reserpate | 2.31e-05 | 2 | 110 | 2 | CID000073532 | |
| Drug | Sulfamerazine | 2.31e-05 | 2 | 110 | 2 | ctd:D013416 | |
| Drug | Midodrine | 2.31e-05 | 2 | 110 | 2 | ctd:D008879 | |
| Drug | triethylmethylammonium | 2.31e-05 | 2 | 110 | 2 | ctd:C043900 | |
| Drug | (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | 2.31e-05 | 2 | 110 | 2 | ctd:C561635 | |
| Drug | Nialamide | 2.31e-05 | 2 | 110 | 2 | ctd:D009526 | |
| Drug | AC1L9OXR | 2.31e-05 | 2 | 110 | 2 | CID000450456 | |
| Drug | glimepiride | 2.34e-05 | 12 | 110 | 3 | ctd:C057619 | |
| Drug | 5-mm AI | 2.34e-05 | 12 | 110 | 3 | CID000131575 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.47e-05 | 177 | 110 | 7 | 2690_UP | |
| Drug | potassium | CACNA1S KCNV2 CHRNA1 CHRNA3 BDKRB2 SLC9A2 SLC24A4 KCNC2 P2RY1 KCNC3 KCNC4 SLC18A2 SCN7A SLC6A5 KCNN1 GPR156 | 2.71e-05 | 1008 | 110 | 16 | CID000000813 |
| Drug | nanofin | 3.72e-05 | 39 | 110 | 4 | CID000068843 | |
| Drug | CID6426996 | 3.84e-05 | 14 | 110 | 3 | CID006426996 | |
| Drug | 3-isoreserpine | 3.89e-05 | 190 | 110 | 7 | CID000005052 | |
| Drug | phenylacetylglutamine | 4.79e-05 | 15 | 110 | 3 | CID000092258 | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HG-U133A | 5.22e-05 | 199 | 110 | 7 | 315_UP | |
| Drug | Dichloroacetic Acid | MCHR1 MFSD2B TMTC2 SERINC2 GPR162 OLR1 TMEM171 SLC9A2 P2RY1 KCNC4 SLC18A1 SLC22A14 CCN2 ABCD2 ALPL | 6.41e-05 | 967 | 110 | 15 | ctd:D003999 |
| Drug | quinuclidinyl benzilate | 6.48e-05 | 87 | 110 | 5 | CID000023056 | |
| Drug | Tyramine | 7.10e-05 | 17 | 110 | 3 | ctd:D014439 | |
| Drug | BQ 123 | 7.20e-05 | 46 | 110 | 4 | CID000123632 | |
| Drug | nomifensine | 7.20e-05 | 46 | 110 | 4 | CID000004528 | |
| Drug | tauroursocholate | 7.77e-05 | 146 | 110 | 6 | CID000005246 | |
| Drug | olmesartan | 8.03e-05 | 91 | 110 | 5 | CID000158781 | |
| Drug | benzetimide | 8.49e-05 | 18 | 110 | 3 | CID000021846 | |
| Drug | talinolol | 8.49e-05 | 18 | 110 | 3 | CID000068770 | |
| Drug | Imipenem | 8.49e-05 | 18 | 110 | 3 | ctd:D015378 | |
| Drug | tetraphenylphosphonium | 1.00e-04 | 19 | 110 | 3 | CID000164911 | |
| Drug | 5,6-dimethylbenzimidazole | 1.00e-04 | 19 | 110 | 3 | CID000000675 | |
| Drug | Histamine | 1.14e-04 | 98 | 110 | 5 | ctd:D006632 | |
| Drug | Famotidine | 1.17e-04 | 52 | 110 | 4 | ctd:D015738 | |
| Drug | tetramethylammonium | 1.26e-04 | 53 | 110 | 4 | CID000006380 | |
| Drug | rifamycin SV | 1.38e-04 | 4 | 110 | 2 | ctd:C023808 | |
| Drug | 6-fluorometaraminol | 1.38e-04 | 4 | 110 | 2 | CID000159475 | |
| Drug | AC1NUTWC | 1.38e-04 | 4 | 110 | 2 | CID005460914 | |
| Drug | microcystin-LF | 1.38e-04 | 4 | 110 | 2 | ctd:C524165 | |
| Drug | 4-(4-dimethylaminostyryl)-1-methylpyridinium | 1.38e-04 | 4 | 110 | 2 | ctd:C032315 | |
| Drug | latanoprost | 1.38e-04 | 4 | 110 | 2 | ctd:C072042 | |
| Drug | norsalsolinol | 1.38e-04 | 4 | 110 | 2 | CID000036937 | |
| Drug | cinchonine | 1.38e-04 | 4 | 110 | 2 | ctd:C010086 | |
| Drug | estrone sulfate | 1.42e-04 | 163 | 110 | 6 | CID000000699 | |
| Drug | Spironolactone | 1.44e-04 | 103 | 110 | 5 | ctd:D013148 | |
| Drug | AC1L1DKE | 1.45e-04 | 55 | 110 | 4 | CID000002388 | |
| Drug | p-aminohippurate | 1.45e-04 | 55 | 110 | 4 | CID000002148 | |
| Drug | estradiol-17 beta-glucuronide | 1.58e-04 | 22 | 110 | 3 | ctd:C025483 | |
| Drug | CI-1034 | 1.58e-04 | 22 | 110 | 3 | CID000157574 | |
| Drug | nitroethane | 1.58e-04 | 22 | 110 | 3 | CID000006587 | |
| Drug | Phentolamine | 1.58e-04 | 22 | 110 | 3 | ctd:D010646 | |
| Drug | Quinine | 1.58e-04 | 22 | 110 | 3 | ctd:D011803 | |
| Drug | sodium cholate | 1.64e-04 | 408 | 110 | 9 | CID000000303 | |
| Drug | pyraclofos | 1.65e-04 | 106 | 110 | 5 | CID000093460 | |
| Drug | perfluorobutanesulfonic acid | 1.81e-04 | 23 | 110 | 3 | ctd:C539348 | |
| Drug | AC1L1KSK | 1.81e-04 | 23 | 110 | 3 | CID000005636 | |
| Drug | Propranolol | 1.88e-04 | 109 | 110 | 5 | ctd:D011433 | |
| Drug | Probenecid | 1.91e-04 | 59 | 110 | 4 | ctd:D011339 | |
| Drug | AC1L1U53 | 2.04e-04 | 60 | 110 | 4 | CID000060907 | |
| Drug | thulium | 2.05e-04 | 111 | 110 | 5 | CID000023961 | |
| Drug | bisphenol F | 2.06e-04 | 24 | 110 | 3 | ctd:C000611646 | |
| Drug | quinoline | 2.18e-04 | 61 | 110 | 4 | CID000007047 | |
| Drug | ATC0175 | 2.29e-04 | 5 | 110 | 2 | CID009934032 | |
| Disease | Alcoholic Intoxication, Chronic | SLCO3A1 SERINC2 PCDH12 PDE10A CHRNA3 SLC17A5 TAS2R16 SLC18A2 CDH8 | 6.57e-07 | 268 | 108 | 9 | C0001973 |
| Disease | Pancreatic Ductal Adenocarcinoma | 7.70e-06 | 11 | 108 | 3 | C1335302 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 1.33e-05 | 2 | 108 | 2 | C4016905 | |
| Disease | Rotor Syndrome | 1.33e-05 | 2 | 108 | 2 | C0220991 | |
| Disease | X-21319 measurement | 1.33e-05 | 2 | 108 | 2 | EFO_0800807 | |
| Disease | Rotor syndrome | 1.33e-05 | 2 | 108 | 2 | cv:C0220991 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 1.33e-05 | 2 | 108 | 2 | 237450 | |
| Disease | X-11478 measurement | 3.97e-05 | 3 | 108 | 2 | EFO_0021242 | |
| Disease | cocaine abuse (implicated_via_orthology) | 3.97e-05 | 3 | 108 | 2 | DOID:809 (implicated_via_orthology) | |
| Disease | N-oleoylserine measurement | 7.93e-05 | 4 | 108 | 2 | EFO_0800525 | |
| Disease | N-oleoyltaurine measurement | 7.93e-05 | 4 | 108 | 2 | EFO_0800337 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 1.32e-04 | 5 | 108 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | 3-hydroxyhexanoate measurement | 1.32e-04 | 5 | 108 | 2 | EFO_0800378 | |
| Disease | indoleacetylglutamine measurement | 1.97e-04 | 6 | 108 | 2 | EFO_0800035 | |
| Disease | indoleacetoylcarnitine measurement | 1.97e-04 | 6 | 108 | 2 | EFO_0800106 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 1.97e-04 | 6 | 108 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 1.97e-04 | 6 | 108 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | deoxycholic acid glucuronide measurement | 3.66e-04 | 8 | 108 | 2 | EFO_0800575 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 4.70e-04 | 9 | 108 | 2 | EFO_0800562 | |
| Disease | liver cancer (is_marker_for) | 4.70e-04 | 9 | 108 | 2 | DOID:3571 (is_marker_for) | |
| Disease | X-21467 measurement | 4.70e-04 | 9 | 108 | 2 | EFO_0020007 | |
| Disease | Congenital myasthenic syndrome | 5.86e-04 | 10 | 108 | 2 | cv:C0751882 | |
| Disease | Thrombus | 6.46e-04 | 46 | 108 | 3 | C0087086 | |
| Disease | Thrombosis | 7.77e-04 | 49 | 108 | 3 | C0040053 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.01e-03 | 13 | 108 | 2 | EFO_0800474 | |
| Disease | creatinine measurement | CACNA1S SERINC2 SLC47A2 BDKRB2 TMEM171 SLC9A2 SPPL2A SLC22A3 SLC47A1 ACSM2B SORD | 1.06e-03 | 995 | 108 | 11 | EFO_0004518 |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.54e-03 | 16 | 108 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Amelogenesis imperfecta | 1.74e-03 | 17 | 108 | 2 | cv:C0002452 | |
| Disease | parahippocampal gyrus volume measurement | 1.95e-03 | 18 | 108 | 2 | EFO_0010318 | |
| Disease | urinary metabolite measurement | 2.11e-03 | 245 | 108 | 5 | EFO_0005116 | |
| Disease | calcium measurement | 2.20e-03 | 628 | 108 | 8 | EFO_0004838 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 2.42e-03 | 20 | 108 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 3.19e-03 | 23 | 108 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 3.19e-03 | 23 | 108 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 3.19e-03 | 23 | 108 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 3.19e-03 | 23 | 108 | 2 | C0014556 | |
| Disease | Colorectal Neoplasms | 3.57e-03 | 277 | 108 | 5 | C0009404 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGFLLPLSVITFCTM | 231 | P30411 | |
| VCILGTAGLFLQPLM | 486 | P32297 | |
| GLIMVAIPIITATGF | 356 | Q9UBJ2 | |
| GILSVIGVMLAPFTA | 151 | Q9BPW4 | |
| GILASLVNGACLPLM | 51 | Q2M3G0 | |
| VILPIVFVTTAMGLG | 1751 | Q86UK0 | |
| LVILGCIRAGLIFMP | 121 | Q08AH3 | |
| VLVCGAGPIGMVTLL | 176 | Q00796 | |
| MSPSGRLCLLTIVGL | 1 | Q96DB9 | |
| LVVGFLLPSVIMIAC | 341 | Q16581 | |
| PFMNLTALIILVGIG | 556 | Q96F81 | |
| TLGIPDVIMGITFLA | 481 | Q8NFF2 | |
| MLTVICLAVLLGIFG | 716 | Q9NPG4 | |
| LGVFMLVCIIGTLAV | 431 | P02708 | |
| LTLGVALVCGVPAMD | 6 | P09466 | |
| TTVAMFCVPLVLILG | 221 | P47900 | |
| MLLSLLGACAVVGPF | 1 | C9J442 | |
| TVGVVVITLPFMCIL | 201 | Q8NGS2 | |
| LCALAGVLTIAMPVP | 456 | Q96PR1 | |
| LLMLVTLTPCAGVSV | 461 | Q6DN12 | |
| CGIVLAEVLTGIPAM | 401 | O43187 | |
| RLLGVCIEMSSQGIP | 651 | Q12866 | |
| VCFSLLLLGGIVMGL | 181 | Q16538 | |
| TLMTICPGTVLLVFS | 276 | Q92952 | |
| FVAPSICIAIIMVGI | 626 | Q99665 | |
| VFSGLCPLLLGSVMA | 116 | P43088 | |
| GCITVTVPAMLGRLL | 81 | P47893 | |
| VGFIMAGTPLVLIIT | 211 | P47893 | |
| GCITVTVPAMLGRLL | 81 | P47888 | |
| ACQVSRMLPGGLLVL | 76 | Q5SWX8 | |
| NILCMPIVSRGSVIG | 366 | Q9Y233 | |
| MSCVLGGVIPLGLLF | 1 | Q9H0B8 | |
| GVVCIAALMLPTLGD | 166 | Q9UJG1 | |
| LGITLMIGGITCILS | 211 | Q9H3U5 | |
| IGAVPTCMILAGLCI | 461 | A6NFX1 | |
| MTIGELIGFVTPLLI | 186 | Q9BXC1 | |
| MAVPGVGLLTRLNLC | 1 | Q9NVV4 | |
| TLGVLCLGLVVTIMV | 41 | P78380 | |
| SSAVMGLLFGVPCLV | 201 | P51582 | |
| MPGSLVLIIILCSVF | 281 | Q9UHC9 | |
| MISPFLVLAIGTCLT | 1 | P05186 | |
| LCMQLILPEAVGGTV | 286 | Q7L5A8 | |
| ILPSMIGIICSTGLV | 36 | Q969V1 | |
| IPGTRVGPTLMCLFV | 1206 | A1KZ92 | |
| MITFLPLLLGLSLGC | 1 | P28068 | |
| TPLPVMTGGFLSCIL | 546 | Q969S8 | |
| MTGGFLSCILGLVLP | 551 | Q969S8 | |
| PAGCMTILPTILFLI | 1771 | Q9P2D3 | |
| VLVLTLNAAGMIIPC | 51 | Q9UFH2 | |
| MVDIVCSPTPFLIGL | 806 | Q9ULE3 | |
| SGAMTPLGISVLRCI | 516 | Q13698 | |
| MGPVRVAFVVLLALC | 6 | P29279 | |
| IMPSVFGTICLLGII | 111 | Q99705 | |
| MLCIGTSLVFGPILG | 126 | Q8NFN8 | |
| PIGLSMGALIAILAC | 616 | P55286 | |
| AMIVGLLIFPIGLAS | 116 | Q6ICI0 | |
| TLVLGGLMCIIIIFI | 396 | Q9Y226 | |
| GLMCIIIIFIPADLP | 401 | Q9Y226 | |
| MAGLPIGSLIFRLIT | 191 | Q9Y267 | |
| MGSGRVPGLCLLVLL | 1 | Q8IX30 | |
| LCVRRIFSLIGMIGP | 361 | Q9NRA2 | |
| IFSLIGMIGPAVFLV | 366 | Q9NRA2 | |
| IIFGILASICGGLVM | 501 | O75751 | |
| LASICGGLVMLLPET | 506 | O75751 | |
| MVLAPCGLLLNLTGT | 11 | Q96B33 | |
| VMIIFAVGGLLALTP | 196 | Q15619 | |
| LGVGIFSVPLLCIIV | 201 | Q9P1Q5 | |
| FVVSVCVLVLPMGLV | 201 | Q5JRS4 | |
| IVAGMVIATPFVCIL | 201 | Q8NGA1 | |
| GGAVILIPFMLILVS | 216 | Q8NH06 | |
| CLVMAIPAILIGAIG | 281 | Q9GZV3 | |
| LGSLMITCVTIIPSA | 131 | Q9NYV7 | |
| VLTLSMAVPPCRVGV | 421 | Q9BYJ4 | |
| MRPLLGLLLVFAGCT | 1 | Q96HV5 | |
| VTYMIPLGLSIGVCV | 336 | Q86VL8 | |
| LGMTAIPCACLGIFL | 391 | Q9UIG8 | |
| IPALQGCGIAMLIIS | 266 | Q9Y345 | |
| VPFIVLGCVVLLMVP | 196 | Q6NT16 | |
| TTTLMACLGGLLGII | 626 | Q9H3W5 | |
| VLGLCMFLTGVSLLP | 121 | Q96AM1 | |
| LKISIPMCLSLGLVG | 626 | Q14697 | |
| PAVRGLLGSCVQLMV | 151 | Q9NY64 | |
| LCIAFGIILNGMPIS | 476 | Q8TDN2 | |
| ITIGMICIFIGVGLT | 196 | Q8N4L2 | |
| LFICAQILIGMGSTP | 266 | Q9H2Y9 | |
| MAGCVPLLQGLVLVL | 1 | P22891 | |
| ILLGVITIPIFASGM | 376 | Q9Y6L6 | |
| LPIGIALMFATTLGV | 421 | Q96FL8 | |
| LLVGVCVACVMLIPG | 46 | Q9NRX5 | |
| PCLFVGTSLGMVLII | 851 | Q9Y2K9 | |
| CFPVLMDIVSNGLLG | 981 | O94911 | |
| LVILGCIRAGLIFMP | 121 | Q68CK6 | |
| LVAVGCMRTGIIFIP | 126 | Q08AH1 | |
| LTEALPVGLIGMNCI | 266 | Q7LG56 | |
| VLGTILTMVRTEGPC | 61 | P55916 | |
| PAVQMGALLLCVLGI | 791 | Q7RTX0 | |
| VLLMSVLLCGLAGPT | 6 | P10745 | |
| SCLLIMVGLLLGGII | 111 | Q9UBY0 | |
| LLIGCLSFPSVIVGI | 411 | O94956 | |
| IPSMGFCLLITVGAR | 426 | Q8N394 | |
| FLLGIITIPTVATGM | 376 | Q9NPD5 | |
| CLMPVSILGFGDIIV | 401 | Q8TCT8 | |
| LSLIPVMGGLALCTA | 201 | P0CK96 | |
| PLLGAMAATLVVICT | 141 | Q495A1 | |
| MGPLIVLVGLCFFVV | 166 | Q8WVE6 | |
| GDLIILITFGPLAVM | 186 | Q9Y5Z9 | |
| VGVTIGCILGMFPLI | 211 | Q6PI78 | |
| IAIVPVFCLMGLLGI | 166 | Q969Z4 | |
| LCLLGAVPMETGVTQ | 11 | A0A589 | |
| VVIFSITGLCLPMTV | 1321 | Q01118 | |
| ALLGMIIVGVSILCI | 361 | Q05940 | |
| LCLLGAVPMETGVTQ | 11 | A0A539 | |
| LFLGVLVSIIMLSPG | 46 | Q96SA4 | |
| IGMLVVGTSLLCVPL | 371 | P54219 | |
| ILGCLFGMVIVLGAV | 401 | Q5R3F8 | |
| ALCALAGVLTIAMPV | 521 | Q14003 | |
| CALAGVLTIAMPVPV | 456 | Q03721 | |
| FIIMGIISLTVTCGL | 71 | Q8NHV5 | |
| LEVACGIVMTLVPGR | 71 | Q53FP2 |